Cargando…

Dysphagia in Head and Neck Cancer Patients: Pretreatment Evaluation, Predictive Factors, and Assessment during Radio-Chemotherapy, Recommendations

Progress in head and neck cancer (HNC) therapies has improved tumor response, loco-regional control, and survival. However, treatment intensification also increases early and late toxicities. Dysphagia is an underestimated symptom in HNC patients. Impairment of swallowing process could cause malnutr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Denaro, Nerina, Merlano, Marco C., Russi, Elvio G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Otorhinolaryngology-Head and Neck Surgery 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781223/ https://www.ncbi.nlm.nih.gov/pubmed/24069513 http://dx.doi.org/10.3342/ceo.2013.6.3.117

Ejemplares similares

Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience
por: Denaro, Nerina, et al.
Publicado: (2016)

The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer
por: Denaro, Nerina, et al.
Publicado: (2013)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC)
por: Denaro, Nerina, et al.
Publicado: (2020)

Head and neck cancer: improving outcomes with a multidisciplinary approach
por: Lo Nigro, Cristiana, et al.
Publicado: (2017)

Further Understanding of the Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: Implications for Prognosis
por: Denaro, Nerina, et al.
Publicado: (2021)

Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide
por: Merlano, Marco C., et al.
Publicado: (2018)

The Role of p53 and MDM2 in Head and Neck Cancer
por: Denaro, N., et al.
Publicado: (2011)

Long noncoding RNAs as regulators of cancer immunity
por: Denaro, Nerina, et al.
Publicado: (2018)

How I treat squamous ENT cancer
por: Merlano, Marco Carlo, et al.
Publicado: (2019)

ASCO highlights podcast: head and neck cancers
por: Merlano, Marco
Publicado: (2016)

Dysphagia Advances in Head and Neck Cancer
por: Patterson, J. M., et al.
Publicado: (2023)

How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review
por: Merlano, Marco Carlo, et al.
Publicado: (2022)

Local and Systemic Pathogenesis and Consequences of Regimen-Induced Inflammatory Responses in Patients with Head and Neck Cancer Receiving Chemoradiation
por: Russi, Elvio G., et al.
Publicado: (2014)

Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it?
por: Merlano, Marco C, et al.
Publicado: (2018)

Quality of life in patients with dysphagia after radiation and chemotherapy treatment for head and neck tumors
por: de Campos, Renata JDS., et al.
Publicado: (2013)

Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck
por: Merlano, Marco, et al.
Publicado: (2007)

Audiological findings in patients treated with radio- and concomitant chemotherapy for head and neck tumors
por: Dell'Aringa, Ana Helena B, et al.
Publicado: (2009)

Assessment of cough in head and neck cancer patients at risk for dysphagia—An overview
por: Mootassim‐Billah, Sofiana, et al.
Publicado: (2021)

IMRT for head and neck cancer: reducing xerostomia and dysphagia
por: Wang, XiaoShen, et al.
Publicado: (2016)

Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review
por: Denaro, Nerina, et al.
Publicado: (2021)

Dysphagia, Speech, Voice, and Trismus following Radiotherapy and/or Chemotherapy in Patients with Head and Neck Carcinoma: Review of the Literature
por: Heijnen, B. J., et al.
Publicado: (2016)

Metastatic disease in head & neck oncology
por: Pisani, Paolo, et al.
Publicado: (2020)

European white paper: oropharyngeal dysphagia in head and neck cancer
por: Baijens, Laura W. J., et al.
Publicado: (2020)

Dysphagia, voice problems, and pain in head and neck cancer patients
por: Zebralla, Veit, et al.
Publicado: (2021)

Predictors of severe dysphagia following radiotherapy for head and neck cancer
por: Petersson, Kerstin, et al.
Publicado: (2021)

Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group
por: Merlotti, Anna, et al.
Publicado: (2014)

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study
por: Pergolizzi, Stefano, et al.
Publicado: (2011)

Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience
por: Denaro, Nerina, et al.
Publicado: (2022)

Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma
por: Girolami, Ilaria, et al.
Publicado: (2023)

An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer
por: Cavalieri, Stefano, et al.
Publicado: (2022)

A Prospective, Longitudinal and Exploratory Study of Head and Neck Lymphoedema and Dysphagia Following Chemoradiotherapy for Head and Neck Cancer
por: Jeans, Claire, et al.
Publicado: (2022)

Change in Nutritional Status and Dysphagia after Resection of Head and Neck Cancer
por: Sadakane-Sakuramoto, Ayumi, et al.
Publicado: (2021)

Dysphagia, hypothyroidism, and osteoradionecrosis after radiation therapy for head and neck cancer
por: Ranta, Pihla, et al.
Publicado: (2021)

Evaluation of Objective and Subjective Swallowing Outcomes in Patients with Dysphagia Treated for Head and Neck Cancer
por: Liou, Hsin-Hao, et al.
Publicado: (2022)

Role of CT Perfusion in Monitoring and Prediction of Response to Therapy of Head and Neck Squamous Cell Carcinoma
por: Preda, Lorenzo, et al.
Publicado: (2014)

Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study
por: Pietsch, Carsten, et al.
Publicado: (2015)

Predictive Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma
por: Chen, Miao-Fen, et al.
Publicado: (2018)

Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT)
por: Peponi, Evangelia, et al.
Publicado: (2011)

Relationship between dysphagia severity and head and neck proprioception in patients with neurological disorders
por: Sevim, Mahmut, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_du0qehlt3mlf19j0277a0gtnh3